Print Page   |   Contact Us   |   Sign In   |   Become a Member
Site Search
News from the Field
Blog Home All Blogs
Search all posts for:   

 

View all (28) posts »
 

News From the Field - November/December 2017

Posted By Connections Editor, Wednesday, November 15, 2017
FDA Grants Breakthrough Therapy Designation for BioMarin's Valoctocogene Roxaparvovec (formerly BMN 270), an Investigational Gene Therapy for Hemophilia A
Biomarin

Novartis submits application to FDA for KymriahTM (tisagenlecleucel) in adult patients with r/r DLBCL, seeking second indication for first-ever FDA approved CAR-T therapy
Novartis

Six papers by disgraced surgeon should be retracted, report concludes
Science
 
Omeros Reports Additional and Consistently Positive Data for OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
Omeros Press Release

This post has not been tagged.

Share |
Permalink | Comments (0)
 
Association Management Software Powered by YourMembership  ::  Legal